Details for New Drug Application (NDA): 021546
✉ Email this page to a colleague
The generic ingredient in REBETOL is ribavirin. There are fifteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ribavirin profile page.
Medical Subject Heading (MeSH) Categories for 021546
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 40MG/ML | ||||
Approval Date: | Jul 29, 2003 | TE: | RLD: | Yes |
Expired US Patents for NDA 021546
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | REBETOL | ribavirin | SOLUTION;ORAL | 021546-001 | Jul 29, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Schering | REBETOL | ribavirin | SOLUTION;ORAL | 021546-001 | Jul 29, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Schering | REBETOL | ribavirin | SOLUTION;ORAL | 021546-001 | Jul 29, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Schering | REBETOL | ribavirin | SOLUTION;ORAL | 021546-001 | Jul 29, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription